Abeona Therapeutics Inc (ABEO) (Q3 2026) Earnings Call Highlights: ZivaSkin Revenue Jumps 18% ...
Abeona Therapeutics Acquires Eosinophilic Esophagitis Drug Candidate for $20 Million in Stock
Abeona Therapeutics Acquires Late-Stage Drug Candidate, Secures $30 Million in Equity Financing
Abeona Therapeutics® Reports Third Quarter 2026 Financial Results and ZEVASKYN® Commercial Progress
Loading...